Online citations, reference lists, and bibliographies.
← Back to Search

Engineering The Nanoparticle-protein Interface For Cancer Therapeutics.

A. Saie, M. Ray, M. Mahmoudi, V. Rotello
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Intracellular delivery of functional proteins using nanoparticles can be a game-changing approach for cancer therapy. However, cytosolic release of functional protein is still a major challenge. In addition, formation of protein corona on the surface of the nanoparticles can also alter the behavior of the nanoparticles. Here, we will review recent strategies for protein delivery into the cell. Finally we will discuss the issue of protein corona formation in light of nanoparticle-protein interactions.
This paper references
10.1016/J.IJPHARM.2007.04.036
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.
Susumu Nagayama (2007)
10.1007/s002800050497
Biological characterization of L-asparaginase liposomal formulations
M. M. Gaspar (1996)
10.1007/S11051-011-0375-2
Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells
D. Guarnieri (2011)
10.1039/b900552h
Size and geometry dependent protein-nanoparticle self-assembly.
Mrinmoy De (2009)
10.1073/PNAS.72.9.3666
An endotoxin-induced serum factor that causes necrosis of tumors.
E. Carswell (1975)
10.4049/jimmunol.166.3.2002
Fibrinogen Promotes Neutrophil Activation and Delays Apoptosis1
C. Rubel (2001)
10.1200/JCO.2009.27.15_SUPPL.3586
Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine.
S. Libutti (2009)
10.1039/b805242e
Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins.
Mrinmoy De (2008)
10.1021/ja406553f
Multiplexed imaging of nanoparticles in tissues using laser desorption/ionization mass spectrometry.
B. Yan (2013)
10.1021/nn305337c
Temperature: the "ignored" factor at the NanoBio interface.
M. Mahmoudi (2013)
10.1073/pnas.1101874108
Protein delivery using engineered virus-like particles
S. J. Kaczmarczyk (2011)
10.1016/J.CLIM.2006.06.006
The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.
T. R. Daniels (2006)
10.1016/j.nano.2011.07.009
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
Christian A. Ruge (2011)
10.1007/BF02071526
In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion
D. Liénard (2005)
10.1172/JCI119411
Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor.
B. Seetharam (1997)
10.1021/nn101557e
Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.
G. Maiorano (2010)
10.1080/10717540490433895
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
G. Paciotti (2004)
10.1021/JA0512881
Tunable inhibition and denaturation of alpha-chymotrypsin with amino acid-functionalized gold nanoparticles.
Chang-Cheng You (2005)
10.1038/nature13302
A draft map of the human proteome
Min-Sik Kim (2014)
10.1039/C2RA22093H
Plasma concentration gradient influences the protein corona decoration on nanoparticles
Mahdi Ghavami (2013)
10.1007/BF00685082
Liposomal palmitoyl-L-asparaginase: characterization and biological activity
J. Jorge (2004)
10.1016/S1359-6446(03)02623-0
Peptide and protein drug delivery to and into tumors: challenges and solutions.
V. Torchilin (2003)
10.1016/0959-8049(94)00512-5
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer.
F. Lejeune (1995)
Role of extracellular matrix assembly in interstitial transport in solid tumors.
P. A. Netti (2000)
10.1002/anie.201400559
Fabrication of multiresponsive bioactive nanocapsules through orthogonal self-assembly.
Yi-Cheun Yeh (2014)
10.1016/j.jcis.2012.10.005
Significance of cell "observer" and protein source in nanobiosciences.
S. Laurent (2013)
10.1016/J.BIOMATERIALS.2005.01.019
Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
D. Labarre (2005)
10.1016/j.ijpharm.2009.03.018
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
Jie Gao (2009)
10.1158/1535-7163.MCT-08-0514
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments
Jie Gao (2008)
10.1073/PNAS.91.21.10119
Complement C3 participation in monocyte adhesion to different surfaces.
A. K. McNally (1994)
10.1021/nn9012274
Size and dynamics of caveolae studied using nanoparticles in living endothelial cells.
Zhenjia Wang (2009)
10.1016/1043-4666(94)90014-0
Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma.
P. Anderson (1994)
10.1016/J.BBRC.2007.11.153
Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier.
T. Yoshikawa (2008)
10.1016/J.ADDR.2005.01.010
Particulate delivery systems for biodefense subunit vaccines.
Vincent W. Bramwell (2005)
10.1016/S0168-3659(99)00146-7
DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.
Qiaoming Ye (2000)
10.1021/ja2084338
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
10.1158/1078-0432.CCR-10-3126
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
M. Cheever (2011)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1016/S0006-2952(00)00498-6
Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy.
L. Folkes (2001)
10.1038/nnano.2010.250
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.
Z. Deng (2011)
10.1002/smll.201200794
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles.
Zheng-Jiang Zhu (2012)
10.1248/BPB.24.662
Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
Y. Li (2001)
Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes.
R. Sitrin (1998)
10.1006/BBRC.1994.1247
Efficient encapsulation of proteins within liposomes for slow release in vivo.
J. Meyer (1994)
10.1007/s00109-005-0030-4
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
V. Zannis (2005)
10.1039/c3cc37307j
Protein corona significantly reduces active targeting yield.
Vahid Mirshafiee (2013)
10.1021/bc100204m
Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.
Suzanne R. Foster (2010)
10.1038/nchem.334
Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein.
Mrinmoy De (2009)
Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity.
L. Kwak (1998)
10.1016/S1389-1723(01)80127-4
On the adsorption of proteins on solid surfaces, a common but very complicated phenomenon.
K. Nakanishi (2001)
10.1002/JBM.A.10371
Functional groups on polystyrene model nanoparticles: influence on protein adsorption.
A. Gessner (2003)
10.1016/S1525-0016(03)00150-3
Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer.
Bouna-Moussa Tandia (2003)
10.1021/nn402753y
Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.
R. Tang (2013)
10.1093/INTIMM/DXH381
An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
D. Wakita (2006)
10.1074/JBC.M207601200
ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells*
U. Panzenboeck (2002)
10.1158/1078-0432.CCR-04-1071
Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen
S. Neelapu (2004)
10.1046/j.1471-4159.2001.00100.x
Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL‐associated vitamin E
D. Goti (2001)
10.1016/j.biomaterials.2011.05.091
Effect of gold nanoparticle morphology on adsorbed protein structure and function.
Jennifer E. Gagner (2011)
10.1517/17425247.2014.924501
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
10.1016/S1476-5586(03)80034-9
The transferrin receptor: a potential molecular imaging marker for human cancer.
Dagmar Högemann-Savellano (2003)
10.1371/journal.pone.0052473
Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation
K. Mellert (2012)
10.1016/S0005-2736(02)00368-1
Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
Manas Mandal (2002)
10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
10.1021/nn300223w
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells.
A. Leśniak (2012)
10.1016/S0022-510X(03)00006-6
Scavenger receptor class B type I expression in murine brain and regulation by estrogen and dietary cholesterol
R. Srivastava (2003)
10.1002/smll.201201492
Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions.
Shengtao Yang (2013)
10.1039/B901616C
Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4 nanoparticles
Avinash Bajaj (2009)
10.1073/pnas.1305804110
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
C. Choi (2013)
10.1038/196476A0
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
L. Vroman (1962)
10.1016/j.jconrel.2012.04.009
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
E. Mahon (2012)
10.1016/j.biomaterials.2011.01.054
Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
S. M. Lim (2011)
10.1016/S0168-3659(02)00083-4
A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture).
E. Kanaoka (2002)
10.1146/ANNUREV.BIOCHEM.75.101304.123901
Protein misfolding, functional amyloid, and human disease.
F. Chiti (2006)
10.1016/j.biomaterials.2007.12.038
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Jongho Kim (2008)
10.1021/nn404166q
Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
Anna Cifuentes-Rius (2013)
10.1021/PR050421L
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.
T. Berggård (2006)
10.1002/9783527632909.CH14
Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins
Y. Zhang (2012)
10.1021/cr2001178
Gold nanoparticles in chemical and biological sensing.
K. Saha (2012)
10.1021/ja107583h
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
M. Monopoli (2011)
10.1039/c3nr32551b
Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles.
M. Mahmoudi (2013)
10.1016/j.bbamem.2009.11.007
Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.
G. Caracciolo (2010)
10.1021/nn5006478
Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity
Daniel F. Moyano (2014)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1021/JA064433Z
Modulation of the catalytic behavior of alpha-chymotrypsin at monolayer-protected nanoparticle surfaces.
Chang-Cheng You (2006)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1021/JP2056255
Large Protein Absorptions from Small Changes on the Surface of Nanoparticles
M. Mahmoudi (2011)
10.1371/journal.pone.0040685
Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma
A. S. Pitek (2012)
10.1038/9504
The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein
R. Kozyraki (1999)
Heterogeneity of tumor cells from a single mouse mammary tumor.
D. Dexter (1978)
10.1021/la202912f
Evolution of the protein corona of lipid gene vectors as a function of plasma concentration.
G. Caracciolo (2011)
10.1038/nnano.2012.237
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
10.1073/PNAS.96.18.10158
Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis.
S. Hammad (1999)
10.1016/J.TOXLET.2003.12.067
The mechanism of indole acetic acid cytotoxicity.
M. P. de Melo (2004)
10.1021/nn101990a
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
I. Hamad (2010)
10.1002/DDR.20066
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors
G. Paciotti (2006)
10.1021/nn2000756
Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line.
Oleg Lunov (2011)
10.1074/jbc.M605229200
MARCO Mediates Silica Uptake and Toxicity in Alveolar Macrophages from C57BL/6 Mice*
R. Hamilton (2006)
10.1021/OL052367K
Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin.
Chang-Cheng You (2005)
10.1680/BBN.12.00027
The protein corona effect for targeted drug delivery
G. Caracciolo (2013)
10.1002/ange.200700465
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.
T. Cedervall (2007)
10.1039/c4cc01257g
Supramolecular tailoring of protein-nanoparticle interactions using cucurbituril mediators.
Yi-Cheun Yeh (2014)
10.1016/j.jconrel.2011.11.028
Clinical impact of serum proteins on drug delivery.
F. Kratz (2012)
10.4155/tde.13.22
Therapeutic potential of cell-penetrating peptides.
L. Vasconcelos (2013)
10.1016/J.CARBON.2009.01.026
Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles
Y. Zhu (2009)
10.1021/nn301389c
Exploiting the protein corona around gold nanorods for loading and triggered release.
J. Kah (2012)
10.1084/JEM.167.1.213
Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies
D. Sahali (1988)
10.1016/J.VACCINE.2006.03.079
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion.
P. Daftarian (2006)
10.1039/C4BM00131A
Personalized protein coronas: a "key" factor at the nanobiointerface.
M. Hajipour (2014)
10.1146/ANNUREV.BIOPHYS.31.101101.140910
NMR studies of lipoprotein structure.
R. J. Cushley (2002)
10.1021/nn901372t
Time evolution of the nanoparticle protein corona.
E. Casals (2010)
10.1016/j.jconrel.2007.12.004
Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins.
L. Liguori (2008)
10.1021/am4014693
Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
A. Paula (2013)
10.1016/j.jconrel.2009.10.014
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
10.1021/cr100440g
Protein-nanoparticle interactions: opportunities and challenges.
M. Mahmoudi (2011)
10.1038/nrm1571
Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling
C. Roy (2005)
10.1038/nnano.2013.181
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.
S. Tenzer (2013)
10.1021/bc200606s
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Raymond P. Briñas (2012)
10.1021/ja907887z
Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles.
P. Ghosh (2010)
10.1074/JBC.M305411200
Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin*
C. Provoda (2003)
10.1098/rsif.2009.0272.focus
Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding
X. Jiang (2009)
10.1038/nnano.2009.341
A novel intracellular protein delivery platform based on single-protein nanocapsules.
Ming Yan (2010)
Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors.
L. Kobzik (1995)
10.1023/A:1012038930172
Tumor Vascular Endothelium: Barrier or Target in Tumor Directed Drug Delivery and Immunotherapy
G. Molema (2004)



This paper is referenced by
Investigation of nanoparticle toxicity: Characterization of protein corona and evaluation of oxidative stress by protein carbonylation
Marc D. Driessen (2016)
10.1021/acs.accounts.7b00051
Nanoparticle-Protein Interactions: Therapeutic Approaches and Supramolecular Chemistry.
M. Kopp (2017)
10.1002/ANGE.201602233
Die Steuerung des Stealth‐Effekts von Nanoträgern durch das Verständnis der Proteinkorona
S. Schöttler (2016)
10.1016/j.biocel.2016.01.005
Protein corona: Opportunities and challenges.
S. Zanganeh (2016)
10.1021/acs.jpclett.7b00442
Ultraviolet Photodissociation of Selected Gold Clusters: Ultraefficient Unstapling and Ligand Stripping of Au25(pMBA)18 and Au36(pMBA)24.
D. Black (2017)
10.2147/IJN.S141582
Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
N. Chaves (2017)
10.1007/s12274-020-2996-1
3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution
Congcong Xu (2020)
10.1371/journal.pone.0183274
Gold nanoparticles partition to and increase the activity of glucose-6-phosphatase in a synthetic phospholipid membrane system
T. MacCormack (2017)
10.1002/anie.201602233
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
S. Schöttler (2016)
10.1002/smll.201906598
Effects of Nanoparticle Electrostatics and Protein-Protein Interactions on Corona Formation: Conformation and Hydrodynamics.
Hwankyu Lee (2020)
10.1016/J.APMT.2018.07.006
Combined photothermal and antibiotic therapy for bacterial infection via acidity-sensitive nanocarriers with enhanced antimicrobial performance
Danfeng He (2018)
10.1016/j.nano.2015.10.019
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Zahra Bakhtiary (2016)
The protein corona of polymeric nanocarriers: characterization and impact on cellular uptake
S. Schöttler (2015)
10.1016/B978-0-08-101925-2.00011-5
Protein Corona: The Challenge at the Nanobiointerfaces
S. Zanganeh (2018)
10.1016/j.colsurfb.2016.09.041
Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
N. Ignjatović (2016)
10.1039/C7RA10970A
Electrostatic attraction driven and shuttle-like morphology assisted enhancement for tumor uptake
Min Lin (2017)
10.1039/c5nr03701h
The biomolecular corona of nanoparticles in circulating biological media.
D. Pozzi (2015)
10.1517/13543776.2016.1163338
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
H. Blanchard (2016)
Semantic Scholar Logo Some data provided by SemanticScholar